Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer

[1]  A. Krasnitz,et al.  Ordered and deterministic cancer genome evolution after p53 loss , 2022, Nature.

[2]  Kaitlin J. Flynn,et al.  Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity , 2022, Science Translational Medicine.

[3]  Jacob D. Jaffe,et al.  Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors. , 2022, Cell stem cell.

[4]  David R. Jones,et al.  Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients , 2021, Cell.

[5]  Eiru Kim,et al.  Improved analysis of CRISPR fitness screens and reduced off-target effects with the BAGEL2 gene essentiality classifier , 2021, Genome Medicine.

[6]  T. Choueiri,et al.  Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies , 2020, Cancer.

[7]  T. Bathala,et al.  Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors. , 2020, Urologic oncology.

[8]  Amber C. Donahue,et al.  Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial , 2020, Nature Medicine.

[9]  Ashton C. Berger,et al.  Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma , 2020, Nature Medicine.

[10]  I. Wistuba,et al.  Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma. , 2020, Cancer cell.

[11]  Steven L. Chang,et al.  Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma , 2020, Nature Communications.

[12]  Sebastian Lange,et al.  Analysis pipelines for cancer genome sequencing in mice , 2020, Nature Protocols.

[13]  J. Espinosa,et al.  Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity , 2019, Proceedings of the National Academy of Sciences.

[14]  R. Motzer,et al.  Towards individualized therapy for metastatic renal cell carcinoma , 2019, Nature Reviews Clinical Oncology.

[15]  A. Amon,et al.  Context is everything: aneuploidy in cancer , 2019, Nature Reviews Genetics.

[16]  T. Margaritis,et al.  Tubuloids derived from human adult kidney and urine for personalized disease modeling , 2019, Nature Biotechnology.

[17]  Matthew C. Canver,et al.  CRISPResso2 provides accurate and rapid genome editing sequence analysis , 2019, Nature Biotechnology.

[18]  Shan Jiang,et al.  Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors. , 2019, Cell reports.

[19]  M. Stratton,et al.  Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma , 2018, bioRxiv.

[20]  L. Cantley,et al.  The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment , 2018, Cell.

[21]  Christopher T. Saunders,et al.  Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.

[22]  G. Mayhew,et al.  Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal , 2018, Cell.

[23]  Ashton C. Berger,et al.  Genomic and Functional Approaches to Understanding Cancer Aneuploidy. , 2018, Cancer cell.

[24]  Steven J. M. Jones,et al.  Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.

[25]  Paul T. Spellman,et al.  The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma , 2018, Cell reports.

[26]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[27]  Mathias J Friedrich,et al.  Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes , 2018, Nature.

[28]  Samuel F. Bakhoum,et al.  Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.

[29]  K. Hess,et al.  Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras , 2017, The Journal of urology.

[30]  Hannah A. Pliner,et al.  Reversed graph embedding resolves complex single-cell trajectories , 2017, Nature Methods.

[31]  Lindsay A. Williams,et al.  MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma , 2017, Nature Communications.

[32]  L. Chin,et al.  Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer , 2017, Nature.

[33]  N. Schultz,et al.  Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets , 2016, Nature Communications.

[34]  J. Wargo,et al.  Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy , 2016, Cell.

[35]  P. Stephens,et al.  Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations. , 2016, European urology.

[36]  Funda Meric-Bernstam,et al.  Punctuated Copy Number Evolution and Clonal Stasis in Triple-Negative Breast Cancer , 2016, Nature Genetics.

[37]  V. Seshan,et al.  FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing , 2016, Nucleic acids research.

[38]  Eric Talevich,et al.  CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing , 2016, PLoS Comput. Biol..

[39]  Chris Sander,et al.  Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. , 2016, Cell reports.

[40]  U. Harmenberg,et al.  Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study , 2016, World Journal of Urology.

[41]  J. Hsieh,et al.  A river model to map convergent cancer evolution and guide therapy in RCC , 2015, Nature Reviews Urology.

[42]  Dian Yang,et al.  Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing , 2015, Genes & development.

[43]  Donavan T. Cheng,et al.  Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.

[44]  Nathan C. Klapoetke,et al.  Transgenic Mice for Intersectional Targeting of Neural Sensors and Effectors with High Specificity and Performance , 2015, Neuron.

[45]  Z. Szallasi,et al.  Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[46]  G. McVean,et al.  Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications , 2014, Nature Genetics.

[47]  Renu Malhotra,et al.  IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples , 2014, PloS one.

[48]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[49]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[50]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[51]  Yueming Ding,et al.  Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn , 2011, Mammalian Genome.

[52]  Thomas M. Keane,et al.  Sequence-based characterization of structural variation in the mouse genome , 2011, Nature.

[53]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[54]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[55]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[56]  H. Pickett,et al.  Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions , 2009, Nature Structural &Molecular Biology.

[57]  Kai Ye,et al.  Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..

[58]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[59]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[60]  Andrew L Kung,et al.  Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination. , 2003, Molecular imaging.

[61]  M. Busslinger,et al.  Nephric lineage specification by Pax2 and Pax8. , 2002, Genes & development.